Abstract:figure legend Daily 1 mg/kg dexamethasone (DEX) treatment in 24‐month‐old female and male mice results in sexually dimorphic effects on skeletal muscle physiology. Short‐term treadmill exercise mitigates the DEX‐induced myopathic features in a sex‐dependent manner. DEX‐treated aged female mice expressed greater sub‐tetanic contractility without an influence of exercise. Exercise protected against DEX‐induced fatigue and losses in muscle mass and soluble protein content in aged females. DEX treatment in aged male mice resulted in a prolonged tetanic half‐relaxation time, increased fatigue and losses in soluble protein content, which were not affected by exercise. Older adults are vulnerable to glucocorticoid‐induced muscle atrophy and weakness, with sex potentially influencing their susceptibility to those effects. Aerobic exercise can reduce glucocorticoid‐induced muscle atrophy in young rodents. However, it is unknown whether aerobic exercise can prevent glucocorticoid myopathy in aged muscle. The objectives of this study were to define the extent to which sex influences the development of glucocorticoid myopathy in aged muscle, and to determine the extent to which aerobic exercise training protects against myopathy development. Twenty‐four‐month‐old female (n = 30) and male (n = 33) mice were randomized to either sedentary or aerobic exercise groups. Within their respective groups, mice were randomized to either daily treatment with dexamethasone (DEX) or saline. Upon completing treatments, the contractile properties of the triceps surae complex were assessed in situ. DEX marginally lowered muscle mass and soluble protein content in both sexes, which was attenuated by aerobic exercise only in females. DEX increased sub‐tetanic force and rate of force development only in females, which was not influenced by aerobic exercise. Muscle fatigue was higher in both sexes following DEX, but aerobic exercise prevented fatigue induction only in females. The sex‐specific differences to muscle function in response to DEX treatment coincided with sex‐specific changes to the content of proteins related to calcium handling, mitochondrial quality control, reactive oxygen species production, and glucocorticoid receptor in muscle. These findings define several important sexually dimorphic changes to aged skeletal muscle physiology in response to glucocorticoid treatment and define the capacity of short‐term aerobic exercise to protect against those changes. Key points There are sexually dimorphic effects of glucocorticoids on aged skeletal muscle physiology. Glucocorticoid‐induced changes to aged muscle contractile properties coincide with sex‐specific differences in the content of calcium handling proteins. Aerobic exercise prevents glucocorticoid‐induced fatigue only in aged females and coincides with differences in the content of mitochondrial quality control proteins and glucocorticoid receptors.

Metabolic pathways implicated in the kinetic impairment of muscle glutamine homeostasis in adult and old glucocorticoid-treated rats.

Dexamethasone treatment affects nuclear glucocorticoid receptor and glucocorticoid response element binding activity in liver of rats (Rattus norvegicus) during aging

Short‐term aerobic exercise prevents development of glucocorticoid myopathic features in aged skeletal muscle in a sex‐dependent manner

Effects of An Omega‐3 High‐Fat Diet on Skeletal Muscle Protein Degradation in Glucocorticoid‐Induced Muscle Wasting

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1α/Lipin1 axis in an aging-related sarcopenia model

Glucocorticoids Enhance Muscle Proteolysis Through a Myostatin-Dependent Pathway at the Early Stage

Contractile regulation of the glucocorticoid-sensitive transcriptome in young and aged skeletal muscle

Mitochondrial Dysfunction Launches Dexamethasone-Induced Skeletal Muscle Atrophy Via AMPK/FOXO3 Signaling.

Timing of glucocorticoid administration determines severity of lipid metabolism and behavioral effects in rats.

Glucocorticoid intermittence coordinates rescue of energy and mass in aging-related sarcopenia through the myocyte-autonomous PGC1alpha-Lipin1 transactivation

Essential Amino Acid-Enriched Diet Alleviates Dexamethasone-Induced Loss of Muscle Mass and Function through Stimulation of Myofibrillar Protein Synthesis and Improves Glucose Metabolism in Mice

The Effects of Omega-3 Fatty Acid Supplementation on Dexamethasone-Induced Muscle Atrophy

Resistance exercise alleviates dexamethasone-induced muscle atrophy via Sestrin2/MSTN pathway in C57BL/6J mice

Gromwell ameliorates glucocorticoid-induced muscle atrophy through the regulation of Akt/mTOR pathway

Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1α.

Chronic Dexamethasone Treatment Leads to Less Weight Gain and Ameliorated Glucose Tolerance in Mice; Role of the Cytoprotective Nrf2 Pathway

Therapeutic effect of androgen on skeletal muscle atrophy induced by glucocorticoid in rat

Pilot investigations into the mechanistic basis for adverse effects of glucocorticoids in dysferlinopathy

Dexamethasone Treatment at the Myoblast Stage Enhanced C2C12 Myocyte Differentiation

Dexamethasone-Induced Protein Degradation in Cultured Myotubes is P300/Hat Dependent

Effects of exercise training on glucocorticoid-induced muscle atrophy: Literature review